Publication of Unaudited (Standalone and Consolidated) Finacials of the Company for the quarter ended June 30, 2025 along with Limited Review Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ZR2 Bioenergy reported zero revenue from operations for Q1 FY26, the same as Q4 FY25, down from ₹149.45 lakhs for the full FY25. The company swung to a standalone profit after tax of ₹30.85 lakhs versus a loss of ₹79.05 lakhs in Q1 FY25, but the profit is driven entirely by other income of ₹46.43 lakhs, with total expenses at just ₹15.67 lakhs. Consolidated PAT was ₹30.54 lakhs. The auditor Bagaria & Co LLP issued an unqualified review opinion. Key context: change of control occurred in December 2024 with ZR2 Group Holdings acquiring 61% stake, the company raised funds via convertible warrants (2.59 crore units at ₹65) and compulsory convertible debentures (1.235 crore units at ₹65), and a new wholly owned subsidiary ZR2 Solar Pvt Ltd was set up in October 2024 for renewable energy business. EPS (basic) for Q1 FY26 stood at ₹0.86.
Core business remains dormant with no operating revenue, so the headline profit is essentially non-operating in nature. Investors should track whether the new solar subsidiary starts generating meaningful revenue, as current earnings do not reflect an operating business. The auditor change (predecessor auditor noted in report) and recent capital raise signal an ongoing business transformation.